PCTC
MESO

Perkins Coie Trust Company’s Mesoblast MESO Stock Holding History

Perkins Coie Trust Company’s Portfolio MESO Stock Details MESO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,500
Closed -$94K – 286
2024
Q3 		$94K Buy
11,500
+1,500
+15% +$10.2K 0.02% 161
2024
Q2 		$68.1K Buy
+10,000
New +$68.4K 0.02% 171

Other funds holding MESO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SXL
Summit X LLC Chesterfield, Missouri $536M AUM 15.36% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
PWM
Prosperity Wealth Management San Ramon, California $300M AUM 28.11% 1-Year Est. Return

Perkins Coie Trust Company's MESO Position: Q4 2024 in Review

Perkins Coie Trust Company sold out of Mesoblast (MESO) in Q4 2024, closing a stake of 11,500 shares — an estimated $94K sold.

Perkins Coie Trust Company first reported a position in MESO in Q2 2024 and held it in 2 quarters. The position peaked at $94K in Q3 2024. 61 funds tracked by Wall St. Rank hold MESO as of Q4 2024.

  • Perkins Coie Trust Company reported no remaining Mesoblast position as of Q4 2024 after selling out during the quarter.
  • Perkins Coie Trust Company sold 11,500 Mesoblast shares in Q4 2024, an estimated $94K.
  • Perkins Coie Trust Company first reported a position in Mesoblast in Q2 2024 and held it in 2 quarters.
  • Perkins Coie Trust Company's Mesoblast position peaked at $94K in Q3 2024.
  • 61 funds tracked by Wall St. Rank held Mesoblast as of Q4 2024.

Based on Perkins Coie Trust Company's 13F filing for Q4 2024, filed 16 Jan 2025.